NCT01415167
PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
COMPLETED
NCT01415167
OBSERVATIONAL
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
The purpose of this registry is to collect information on patients who are receiving treatment with Proleukin in an organized way, and to learn more about patient care during and after treatment.
Inclusion Criteria:
* 18 years or older
* Must have received at least one course of high dose IL-2 or Proleukin
* Signed informed consent form
Exclusion Criteria:
* Prior high dose IL-2 or Proleukin therapy
Metastatic Renal Cell Carcinoma
Metastatic Melanoma
- Prometheus Laboratories